Denali Therapeutics Stock Price

-0.41 (-1.3%)
Upgrade to Real-Time
Regular Market
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Denali Therapeutics Inc DNLI NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Previous Close Last Traded
-0.41 -1.3% 31.25 31.21 34.8777 32.5746 31.66 11:59:06
Bid Price Ask Price Spread Spread % News
31.21 31.32 0.11 0.35% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
9,290 870,575 $ 33.01 $ 28,734,664 571,049 12.39 - 35.70
Last Trade Time Type Quantity Stock Price Currency
11:59:06 100 $ 31.25 USD

Denali Therapeutics Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 3.50B 105.63M 59.61M $ 26.68M $ - -2.07 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Denali Therapeutics News

Date Time Source News Article
8/06/202009:17Dow Jones NewsBiogen to Buy Stake in Denali for $465 Million as Part of..
8/06/202008:52Edgar (US Regulatory)Current Report Filing (8-k)
8/06/202008:07GlobeNewswire Inc.Denali Therapeutics Announces Decision to Advance DNL151..
8/06/202008:02GlobeNewswire Inc.Biogen and Denali to Collaborate on LRRK2 Program for..
7/29/202009:00GlobeNewswire Inc.Denali Therapeutics Announces Phase 1b Study by Partner..
7/07/202008:00PR Newswire (US)Flagship Pioneering's Scientists Invent a New Category of..
6/30/202019:18Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical DNLI Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week24.1235.7022.7530.151,548,6417.1329.56%
1 Month26.9735.7022.3627.77690,5454.2815.87%
3 Months22.9435.7021.4126.36614,2778.3136.22%
6 Months25.3335.7012.3923.16565,3835.9223.37%
1 Year18.4635.7012.3921.69495,29812.7969.28%
3 Years21.5535.7012.3220.56428,0819.7045.01%
5 Years21.5535.7012.3220.56428,0819.7045.01%

Denali Therapeutics Description

Denali Therapeutics Inc is a biotechnology company which is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include LRRK2 Inhibitor Program which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle) and others.
Your Recent History
Denali The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200807 16:14:06